Connecticut Emerging Infections Program: Project Abstract
Emerging Infections Program Application FOA# CDC-RFA-CK17-1701. Federal Centers for Disease Control and Prevention (CDC); Emerging Infections Program (EIP); New – Type 1
The Connecticut Emerging Infections Program (CT EIP) was established in 1995 and is a joint effort between the State of Connecticut Department of Public Health (DPH), the Yale School of Public (YSPH) office of the Emerging Infections Program (Yale EIP), and the Centers for Disease Control and Prevention (CDC). The CT EIP receives all of its funding through a cooperative agreement with the CDC and has been funded from 1995 through Fiscal Year 2016. The goals of the EIPs are to assess the public health impact of emerging and re-emerging infections and to evaluate methods for their prevention and control. The CT EIP encompasses six programmatic activities conducted at the DPH and the Yale EIP including four required activities and two optional activities included in this application. The activities include:
1. Active Bacterial Core Surveillance (ABCS) project conducts active population-based laboratory surveillance to assess the public health impact of emerging invasive disease due to Streptococcus pneumoniae, group A Streptococcus, group B Streptococcus, Haemophilus influenzae, and Neisseria meningitidis to evaluate methods for their prevention and control.
2. Foodborne Diseases Active Surveillance Network (FoodNet) project conducts active population-based surveillance to determine the burden of illness due to bacterial and parasitic pathogens commonly transmitted through food including Campylobacter, Listeria, Salmonella, Shiga toxin-producing E. coli (STEC) O157 and non-O157, Shigella, Vibrio, Yersinia, Cryptosporidium, and Cyclospora, and for hemolytic uremic syndrome (HUS), to identify risk factors for infection.
3. Healthcare Associated Infections – Community Interface (HAIC) project conducts population-based surveillance for Clostridium difficile (CDI), methicillin resistant/susceptible Staphylococcus aureus (MRSA/MSSA) to determine the incidence of community-and healthcare-associated infections; characterize pathogen strains responsible for infection with a focus on community-associated cases; and describe the epidemiology of CDI, MRSA and MSSA and generate hypotheses for future research activities. The HAIC Prevalence and Antimicrobial Use Surveys seeks to characterize the scope and nature of healthcare associated infections and use of antimicrobials in US healthcare facilities.
4. Influenza surveillance project (FluSurv-NET) conducts population-based surveillance to provide near real-time weekly rates of influenza hospitalizations to monitor the severity of each influenza season, inform annual estimations of disease burden, assess circulating strains of influenza and describe the morbidity and mortality associated with new and existing strains of influenza in the community and assess uptake and effectiveness of vaccination and antiviral treatment.
5. Human Papillomavirus (HPV) Vaccine Impact (HPV-IMPACT) conducts population-based surveillance for high-grade cervical lesions and characterizes HPV strains associated with these lesions to monitor the early impact of HPV vaccination and to examine important questions about health disparities in HPV vaccine impact.
6. Lyme disease and Other Tickborne Diseases (TickNET) project conducts activities designed to evaluate the level of protection against tickborne diseases afforded by available residential prevention measures (e.g. acaricide application, rodent targeted bait boxes) and personal preventions measures (e.g., permethrin treated clothing), evaluate the economic burden of Lyme disease, monitor distribution of ticks and tickborne pathogens and foster continued tickborne pathogen discovery.